Clinical Trial Update: Chemoembolization for Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating chemoembolization for hepatocellular carcinoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: TERMINATED